(Reuters) – Swiss drugmaker Actelion‘s 2016 core net income rose 27 percent on accelerating sales of its newer medicines to treat deadly pulmonary arterial hypertension (PAH), it said on Tuesday. Core net income rose to 881 million Swiss francs ($877.8 million) from 693 million francs in the previous year, the company said in a statement. […]
MassDevice Earnings Roundup
Teva Pharmaceutical beats Q4 earnings, sales estimates
Shares in Teva Pharmaceutical (NYSE:TEVA) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results. The Israel-based company posted a loss of -$974 million on sales of $6.49 billion for the 3 months ended Dec. 31, for bottom-line loss of -296% on sales growth of 33% compared with the same period last […]
NuVasive posts Street-beating Q4, FY2016
Shares in NuVasive Inc. (NSDQ:NUVA) have fallen in after-hours trading despite the medical device maker meeting expectations on the street with its Q4 and fiscal year 2016 earnings. The San Diego, Calif.-based company posted profits of $6.4 million, or 11¢ per share, on sales of $271.1 million for the 3 months ended December 31, for a […]
pSivida shares gain on Q2 earnings
Shares in pSivida (NSDQ:PSDV) rose yesterday after the medical device maker met expectations on Wall Street with its fiscal 2nd quarter results. The Watertown, Mass.-based company pared its losses to -$0.1 million, or 0¢ per share, on sales of $6 million for the 3 months ended Dec. 31, for bottom-line growth of 98.7% on sales […]
Smith & Nephew misses the mark with 2016 results
Smith & Nephew (NYSE:SNN) today posted 2016 numbers that missed the consensus forecast, sending share prices down today in London and New York despite a net profit gain of more than 91%. Europe’s largest large-joint implant maker reported 2016 trading profits of $1.02 billion, off by -7.2% compared with 2015, on 0.8% sales growth to $4.67 billion. […]
Allergan ticks up on Q4, 2016 beats
Allergan (NYSE: AGN) shares ticked up today after the company reported 4th-quarter and full-year earnings – and a 2017 sales forecast – that beat expectations on Wall Street. The drugmaker narrowed its losses by 90% to -$70.2 million, or -20¢ per share, on sales growth of 7.1% to $3.86 billion for the 3 months ended Dec. 31, […]
Cardinal Health shares rise on Q2 EPS beat
Shares in Cardinal Health (NYSE:CAH) rose today after the medical device maker topped earnings per share expectations on Wall Street with its 2nd quarter results. The Dublin, Ohio-based company posted profits of $324 million, or $1.02 per share, on sales of $33.1 billion for the 3 months ended December 31, with the bottom-line shrinking 0.6% while […]
Haemonetics posts Q3 beat, lifts guidance
Haemonetics (NYSE:HAE) today released its 3rd quarter earnings, topping expectations from analysts on The Street and raising its outlook for the rest of its fiscal year 2017. The Braintree, Mass.-based company posted profits of $15.4 million, or 30¢ per share, on sales of $227.8 million for the 3 months ended Dec. 31, for a significant swing […]
Amgen tops Q4 earnings, touts Repatha cardiovascular outcomes
Shares in Amgen (NSDQ:AMGN) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results and touted data from a trial for its cholesterol drug, Repatha. The Thousand Oaks, Calif.-based company posted profits of $1.94 billion, or $2.59 per share, on sales of $5.97 billion for the 3 months ended Dec. 31, for bottom-line […]
ConMed slides on Q4 earnings miss
ConMed (NSDQ:CNMD) shares are off some 6% this week after the medical device company missed expectations with its 4th-quarter earnings. Utica, N.Y.-based ConMed posted a -14.6% profit decline to $6.7 million, or 24¢ per share, on sales growth of 6.8% to $204.1 million for the 3 months ended Dec. 31, compared with Q4 2015. Adjusted […]
Nordisk tumbles on lowered outlook
Shares in Novo Nordisk (NYSE:NVO) fell -9% this morning after the pharmaceutical company missed expectations on Wall Street with its 4th quarter results and lowered its outlook for 2017. The Danish company posted profits of 8.7 billion Danish kroner, or $1.26 billion USD, on sales of 29.57 billion kroner for the 3 months ended Dec. 31, for bottom-line growth of […]